The volume of collected genetic data has been growing exponentially in the past few years and we need to improve the way we store, analyze and visualize it in order to be able to draw relevant conclusions that could improve the life quality of people. Extracting patterns and predicting future mutations and their impact will rely heavily on the efficient use of Big Data. Often a mutation on its own cannot provide enough information about a disorder or disease. Only if we combine the genetic information with the organism's environment we can draw some conclusions about penetrance and expressively of the mutation. Because many genes can cause a single disease and at the same time a single gene can cause multiple diseases, we need to analyze the whole context of a person.
Introduction
The volume of collected genetic data has been growing exponentially in the past few years and we need to improve the way we store, analyze and visualize it in order to be able to draw relevant conclusions that could improve the life quality of people. Extracting patterns and predicting future mutations and their impact will rely heavily on the efficient use of Big Data. Often a mutation on its own can not provide enough information about a disorder or disease. Only if we combine the genetic information with the organism's environment we can draw some conclusions about penetrance and expressivity of the mutation [1] . Because many genes can cause a single disease and at the same time a single gene can cause multiple diseases, we need to analyze the whole context of a person. Big data is the term used for describing large collections of data sets that will be analyzed, visualized and transferred [2] . Besides the implied requirement for high performance, database management systems need to be also highly available. That means no down time for the system and it can be ensured by replicating the data on multiple nodes. In the vast context of genetic mutations, Big Data constitutes all the information related to a gene and its possible anomalies that is stored and will be used for further analysis. The complexity of the medical data will increase with the advancement of technologies and techniques, so a database structure schema has to be able to assimilate it. Incorporating easily new characteristics into an existing system and not be constrained by an initial rigid design is why it makes sense for Big Data and Genetic Mutation information to be associated. In this work, a distributed solution that provides demographics and metrics about diagnostics and mutations is proposed. Seeing the occurrence of a mutation in a particular geographic region can help medical specialists narrow down the search for a patient's mutations without sequencing the whole genome. The open source project is available at [7] and it contains details about the installation of the distributed database management system.
Methods
In this prototype we store information regarding the patient's gender, location, age, the age when diagnosed, date of death if applicable, all discovered disorders with afferent mutations and for each mutation, its locus, professional exposure substances and exposure time to each of them [4] . With the proposed approach, the nonrelational database Apache Cassandra [5] is chosen, as a suitable candidate for storing medical data. There are several other options that have been previously benchmarked [3] . The scope of this proof of concept is designing a data model that considers external exposure factors along with demographic information about the patients to provide a visual aggregation and it does not include a comparison between database management systems. To ensure replication and high availability, a number of three Cassandra nodes are deployed in a cluster through Docker [6]. In Figure 1 , a sample map about existing mutations is displayed (using mock data auto generated based on real mutations, genes and disorder names), and the intensity of the blue color reflects the number of mutations encountered.
Figure 1: Mutation Frequency Map
Using the principle: "A picture is worth a thousand words", our proof of concept reduces the time required to perform an analysis. In a couple of seconds, the frequency of a mutation in a given region can be inspected, without needing to scroll through a very large table for getting the relevant information. After the search is significantly narrowed down, a data export can be performed in either .csv (comma separated values) or .pdf (Portable Document Format) format.
Results
The information can be filtered and the number of mutations displayed per country and a new analysis is retrieved on demand in a couple of seconds, thus simplifying the visualization process. An example of use case after having real data could be the following: A medical specialist, can visualize on each country the number of women that were diagnosed at the age of 35 with Breast Cancer, have the mutation c.3548A>G on gene BRCA1, is currently under treatment and were professionally exposed to chemical agent ethylene oxide. The time needed for aggregating the existing mutations in the database on country is 1.3 seconds for 100 000 results and goes up to 18.2 for 1 million results. Insert time on the other hand takes 17 seconds for 100 000 and up to 181 seconds for 1 million records. The tests were performed on a computer with 16GB of memory and a 2Ghz Intel Core i7 processor. In our case, the database will be interrogated frequently for performing on demand analyses. Inserts will be done one at the time. Large volumes of data would need to imported only when migrating from an existing Database Management System.
Conclusions
The novelty of our solution is that it provides geographical clustering of mutations associated to professional exposure factors while preserving information about the patient's background. Using the proposed Data Model, correlations can be done about how the person's environment and exposure to harmful chemicals can cause mutations or accentuate the effects of existing inherited ones.
